Request availability and a quotation for your required quantity and destination.
| Product | Semaglutide 3 mg - Semalix 3 |
|---|---|
| Categories | Weight Loss |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Composition: Oral semaglutide 3 mg
Listed brand: Semalix 3
Form: Oral tablet
Prescription medicine: Yes
Semalix 3 is listed as a semaglutide tablet for adults with type 2 diabetes. Semaglutide is a GLP-1 receptor agonist used to improve blood glucose management with appropriate nutrition and activity. Verify the manufacturer, exact formulation and packaging before clinical use.
Semaglutide activates GLP-1 receptors, promoting glucose-dependent insulin secretion, reducing glucagon and slowing gastric emptying. Its effects and tolerability vary by patient.
The 3 mg strength in the conventional oral semaglutide 3/7/14 mg regimen is generally an initiation dose rather than the maintenance dose. The prescriber determines subsequent titration.
Follow the exact leaflet for the supplied formulation. Conventional 3/7/14 mg oral semaglutide is generally swallowed whole on an empty stomach with up to 120 mL plain water, with at least 30 minutes before food, drinks or other oral medicines. Different oral formulations are not necessarily interchangeable milligram-for-milligram.
Nausea, vomiting, diarrhoea, constipation and stomach discomfort are common. Important risks may include pancreatitis, gallbladder problems, worsening kidney function with dehydration, diabetic retinopathy complications and hypoglycaemia with certain diabetes medications. U.S. semaglutide labeling contraindicates use in people with a personal or family history of medullary thyroid carcinoma or MEN2, or serious hypersensitivity to semaglutide. Consult a prescriber about pregnancy and concomitant medicines.
Semalix 3 mg · Semalix 7 mg · Semalix 14 mg
FDA labeling database — oral semaglutide provides regulatory information. Consult the supplied Semalix manufacturer leaflet for product-specific instructions.
No. Oral semaglutide is not a treatment for type 1 diabetes.
Do not switch on your own. Formulations and doses can differ; a clinician must evaluate any change.
Yes. Enquiries are subject to prescription documentation, availability, product verification and destination-country law.
For a general discussion of weight-management treatments, see orlistat versus semaglutide. Different formulations and indications are not interchangeable; consult the prescribing clinician.
This content is for education and enquiry only, not a personalized treatment recommendation. Sources checked October 2026; independent physician sign-off and pack-specific medical verification are not claimed.